ClearPoint Neuro, Inc. (CLPT) Balance Sheet
As of 2026-06-30 (10-Q), ClearPoint Neuro, Inc. (CLPT) reported total assets of $86.7M, total liabilities of $76.0M and shareholders' equity of $10.8M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $29.4M. Long-term debt: $50.2M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CLPTClearPoint Neuro, Inc.Follow CLPT — free
—
Price chart with a free account
- Market cap
- 278.8M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 28 Oct, in 4 days
| Line | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1.6 | 3.5 | 9.2 | 5.4 | 3.3 | 9.3 | 3.1 | 5.7 | 20.1 | 54.1 | 27.6 | 23.1 | 20.1 | 45.9 | 29.4 | |
| Short-term investments | — | — | — | — | — | — | — | — | — | 0.0 | 9.9 | 0.0 | — | — | — | |
| Receivables | 0.4 | 0.8 | 0.5 | 1.2 | 0.9 | 0.9 | 1.2 | 1.1 | 1.9 | 2.3 | 2.7 | 3.2 | 4.7 | 6.5 | 8.4 | |
| Inventory | 0.9 | 1.5 | 2.0 | 1.8 | 1.8 | 2.3 | 2.1 | 3.2 | 3.2 | 4.9 | 9.3 | 7.9 | 6.9 | 8.4 | 8.8 | |
| Current assets | 3.1 | 5.9 | 11.7 | 8.5 | 6.1 | 12.7 | 6.7 | 10.4 | 25.5 | 61.9 | 51.2 | 36.2 | 33.4 | 63.6 | 48.9 | |
| Total assets | 5.6 | 7.9 | 13.4 | 9.9 | 7.4 | 13.9 | 7.9 | 11.9 | 29.5 | 65.6 | 55.5 | 42.7 | 39.2 | 97.7 | 86.7 | |
| Current liabilities | 6.3 | 10.1 | 4.9 | 7.7 | 3.0 | 4.4 | 1.9 | 3.8 | 3.2 | 4.8 | 6.8 | 7.4 | 10.4 | 10.8 | 10.3 | |
| Long-term debt | 2.0 | 3.9 | 11.0 | 8.1 | 4.5 | 4.9 | 3.5 | 2.1 | 21.3 | 9.8 | 9.9 | 9.9 | 0.0 | 49.1 | 50.2 | |
| Short-term debt | — | — | — | 4.2 | — | 2.0 | — | — | — | — | — | 0.0 | — | — | — | |
| Total liabilities | 13.4 | 14.7 | 13.5 | 11.9 | 8.2 | 8.1 | 6.3 | 7.3 | 27.1 | 16.8 | 18.6 | 21.5 | 13.8 | 69.7 | 76.0 | |
| Shareholders' equity | -7.9 | -6.8 | -0.1 | -2.0 | -0.8 | 5.8 | 1.5 | 4.6 | 2.4 | 48.8 | 36.9 | 21.2 | 25.4 | 28.0 | 10.8 |
USD millions · SEC XBRL
ClearPoint Neuro, Inc. — questions
- How much cash does ClearPoint Neuro, Inc. have?
- $29.4M in cash and cash equivalents as of 2026-06-30.
- How much debt does ClearPoint Neuro, Inc. have?
- $50.2M of long-term debt as of 2026-06-30.
- What are ClearPoint Neuro, Inc.'s total assets?
- $86.7M as of 2026-06-30.
- What is ClearPoint Neuro, Inc.'s shareholders' equity?
- $10.8M as of 2026-06-30.
Every figure on this page comes from ClearPoint Neuro, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.